NEW YORK (GenomeWeb) – BGI Europe and molecular diagnostics firm Genomed this week announced a partnership to offer BGI's non-invasive prenatal test in Poland.

The deal makes Genomed Poland's leading service provider of the test called NIFTY, the firms said. NIFTY detects the risk of certain genetic conditions, including Down syndrome, from as early as 10 weeks into the pregnancy.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.